Suppr超能文献

儿童使用草药引起的类过敏即时反应:一项基于VigiBase数据的回顾性研究。

Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase.

作者信息

Meincke Ricarda, Pokladnikova Jitka, Straznicka Julie, Meyboom Ronald H B, Niedrig David, Russmann Stefan, Jahodar Ludek

机构信息

Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic.

WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden.

出版信息

Pediatr Allergy Immunol. 2017 Nov;28(7):668-674. doi: 10.1111/pai.12778. Epub 2017 Oct 3.

Abstract

BACKGROUND

The use of herbal medicines in children and the general population is continually on the rise with an overall herbal lifetime and current use ranging between 0.8%-85.5% and 2.2%-8.9%, respectively. Although acute hypersensitivity reactions are generally considered to be rare, little knowledge exists on the frequency and type of these reactions especially in specific populations like children.

OBJECTIVES

To assess the patterns of acute hypersensitivity reactions to herbal medicines reported to the WHO global individual case safety report (ICSR) database VigiBase in children.

STUDY DESIGN

From the original VigiBase extract for the time between 1968 and 2014, we included all reports with adverse drug reactions (ADR) associated with herbal medicines in children where WHO-ART reaction terms were indicative of acute hypersensitivity reactions.

RESULTS

VigiBase contained 2646 ICSRs with 14 860 distinct adverse reactions reported in association with herbal medicine in children. Among those, 79 cases with 107 allergy-like reactions met our inclusion criteria. The most commonly reported WHO-ART terms were urticaria or rash/rash erythematous (59.8%), and allergic reaction (8.4%). The most frequently reported suspected herbal medicines were mixed herbal products (51.4%), Hedera helix (15.0%), and Echinacea purpurea (5.6%). Most frequent routes of administration were oral (75.9%), topical (8.9%), and rectal (3.8%). Over 30% of cases were reported in the age group from 7 to 12 years. The majority of reports were received from Germany (29.1%), Thailand (21.5%), and Australia (11.4%).

CONCLUSION

VigiBase contains a considerable number of acute hypersensitivity reactions in children associated with herbal medicines, including life-threatening reactions such as anaphylactic shock.

摘要

背景

儿童及普通人群中使用草药的情况持续增加,草药的终生使用率和当前使用率分别在0.8% - 85.5%和2.2% - 8.9%之间。尽管一般认为急性过敏反应较为罕见,但对于这些反应的频率和类型,尤其是在儿童等特定人群中的情况,人们了解甚少。

目的

评估向世界卫生组织全球个体病例安全报告(ICSR)数据库VigiBase报告的儿童草药急性过敏反应模式。

研究设计

从1968年至2014年期间的原始VigiBase提取物中,我们纳入了所有与儿童草药相关的药物不良反应(ADR)报告,其中世界卫生组织药物不良反应术语表明为急性过敏反应。

结果

VigiBase包含2646份ICSR,报告了与儿童草药相关的14860种不同的不良反应。其中,79例有107种过敏样反应符合我们的纳入标准。最常报告的世界卫生组织药物不良反应术语是荨麻疹或皮疹/红斑性皮疹(59.8%)和过敏反应(8.4%)。最常报告的可疑草药是混合草药产品(51.4%)、常春藤(1十五.0%)和紫锥菊(5.6%)。最常见的给药途径是口服(75.9%)、局部(8.9%)和直肠(3.8%)。超过30%的病例报告来自7至12岁年龄组。大多数报告来自德国(29.1%)、泰国(21.5%)和澳大利亚(11.4%)。

结论

VigiBase包含大量与儿童草药相关的急性过敏反应,包括过敏性休克等危及生命的反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验